Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study

Abdul Majeed Akhtar1, Sadia Majeed2, Muhammad Jamil3

  • 1Dr. Abdul Majeed Akhtar, MBBS, DTCD, DPH, MCPS, Ph.D. Department of Epidemiology and Public Health, University of Veterinary & Animal Sciences, Lahore, Pakistan. Program Manager, Provincial TB Control Program, Punjab, DGHS, 24 Cooper Road Lahore, Pakistan.

Insights

Hepatitis C virus (HCV) infection is prevalent in 36.09% of injecting drug users (IDUs) in Lahore. Sharing syringes and reusing them significantly increases HCV risk, with genotype 3a being the most common subtype.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge, particularly among vulnerable populations.
  • Injecting drug users (IDUs) are a key demographic for HCV transmission due to high-risk behaviors.

Purpose of the Study:

  • To determine the prevalence of HCV infection among IDUs in Lahore.
  • To identify risk factors associated with HCV infection in this population.
  • To analyze HCV genotypes and their correlation with viral load.

Main Methods:

  • Screening of 241 IDUs for Anti-HCV antibodies using ELISA.
  • RT-PCR for viral load and genotyping of positive samples.
  • Statistical analysis using SPSS, with p<0.05 considered significant.

Main Results:

  • HCV prevalence among Lahore IDUs was 36.09%.
  • Significant risk factors included low education, low socioeconomic status, blood transfusion, tattoos, and syringe reuse/sharing.
  • HCV genotype 3a was the most prevalent subtype (n=65), followed by 2a (n=15) and 1a (n=6).

Conclusions:

  • Syringe reuse and sharing are major risk factors for HCV infection among IDUs.
  • Viral load in IDUs shows a significant association with different HCV genotypes.
Abstract